What does a successful go-to-market strategy look like? How can it evolve as a company reinvents itself? Keynote speaker Paul Wengender of Blue Sky Biotech would say success is built upon clear vision, decisive action, shared values, and productive external partnerships.
For the past 25 years, Wengender has been an articulate and energetic leader of high-performance teams engaged in the competitive environment of early phase drug discovery. His path includes graduate studies at Penn State University and Boston University, research within the labs of Pfizer and AstraZeneca, and more recently as Founder, and for 10 years CEO, of Blue Sky Biotech. Paul recently founded Crow's Nest BioVentures, a consulting firm that carries on his passion for leadership and strategy in the life cycle of new technology and service businesses within the life science marketplace.
Joining Paul in a panel discussion will be Kevin O’Sullivan, President and CEO of Massachusetts Biomedical Initiatives (MBI), a private economic development organization that promotes the growth and expansion of the biotechnology, medical device and bioinformatics industry, and Charles Garniewicz, Director of Research and Development for Kinefac Corporation, a 50-year Worcester manufacturer and world leader in precision metal forming and processing technology.
Charles Garniewicz has worked for Kinefac for more than 40 years. He is a graduate of Northeastern University with a bachelor of science degree in mechanical engineering.
MBI operates four life science business incubator facilities in Worcester, providing cost-effective laboratory space and high quality business development and commercialization services to more than 20 companies with approximately 100 employees. Kevin O’Sullivan was previously Vice President and Director of Marketing in a combined public/private partnership position with the Worcester Regional Chamber of Commerce and the City of Worcester.
From 1986 to 1994, Kevin was a member of the Massachusetts House of Representatives. He previously served on the Worcester Business Development Corporation and was part of the development team which created the highly successful one million square foot Massachusetts Biotechnology Research Park. The former Chair of the City of Worcester’s License Commission, Kevin is a member of the Reliant Medical Group Board of Trustees. He is also active in many civic and community activities.